DOMO INC - CLASS B (DOMO)

US2575541055 - Common Stock

7.62  +0.19 (+2.56%)

After market: 7.62 0 (0%)

Fundamental Rating

2

Overall DOMO gets a fundamental rating of 2 out of 10. We evaluated DOMO against 276 industry peers in the Software industry. Both the profitability and financial health of DOMO have multiple concerns. DOMO is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

DOMO had negative earnings in the past year.
In the past year DOMO had a positive cash flow from operations.
In the past 5 years DOMO always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: DOMO reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -33.49%, DOMO is doing worse than 74.82% of the companies in the same industry.
Industry RankSector Rank
ROA -33.49%
ROE N/A
ROIC N/A
ROA(3y)-39.62%
ROA(5y)-43.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DOMO's Gross Margin of 76.34% is fine compared to the rest of the industry. DOMO outperforms 72.26% of its industry peers.
In the last couple of years the Gross Margin of DOMO has grown nicely.
DOMO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.51%
GM growth 5Y3.21%

0

2. Health

2.1 Basic Checks

DOMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DOMO has been increased compared to 1 year ago.
DOMO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOMO is higher compared to a year ago.

2.2 Solvency

DOMO has an Altman-Z score of -8.08. This is a bad value and indicates that DOMO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.08, DOMO is doing worse than 87.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.08
ROIC/WACCN/A
WACC10.87%

2.3 Liquidity

DOMO has a Current Ratio of 0.65. This is a bad value and indicates that DOMO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.65, DOMO is doing worse than 90.15% of the companies in the same industry.
DOMO has a Quick Ratio of 0.65. This is a bad value and indicates that DOMO is not financially healthy enough and could expect problems in meeting its short term obligations.
DOMO has a Quick ratio of 0.65. This is amonst the worse of the industry: DOMO underperforms 89.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65

4

3. Growth

3.1 Past

DOMO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.50%, which is quite impressive.
DOMO shows a small growth in Revenue. In the last year, the Revenue has grown by 3.35%.
Measured over the past years, DOMO shows a quite strong growth in Revenue. The Revenue has been growing by 17.49% on average per year.
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-150%
Revenue 1Y (TTM)3.35%
Revenue growth 3Y14.92%
Revenue growth 5Y17.49%
Revenue growth Q2Q0.71%

3.2 Future

Based on estimates for the next years, DOMO will show a very strong growth in Earnings Per Share. The EPS will grow by 31.54% on average per year.
DOMO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y-74.25%
EPS Next 2Y16.36%
EPS Next 3Y31.54%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y1.8%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

DOMO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DOMO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

DOMO's earnings are expected to grow with 31.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.36%
EPS Next 3Y31.54%

0

5. Dividend

5.1 Amount

No dividends for DOMO!.
Industry RankSector Rank
Dividend Yield N/A

DOMO INC - CLASS B

NASDAQ:DOMO (4/25/2024, 3:20:03 PM)

After market: 7.62 0 (0%)

7.62

+0.19 (+2.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap289.79M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.49%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 76.34%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-74.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.35%
Revenue growth 3Y14.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y